Novartis to commence subsequent offering period for Genoptix, Inc.

This subsequent offering period will expire at 12:00 midnight (New York City time) on March 4, 2011 (which is the end of day on March 4, 2011). Shares that are validly tendered during the subsequent offering period may not be withdrawn and will immediately be accepted for payment. The holders of tendered shares will be promptly paid the same amount per share offered in the initial offering period.

The depositary for the tender offer has advised Novartis that, as of midnight on February 25, 2011 when the initial offering period was completed, approximately 79.81% of Genoptix's outstanding shares of common stock were tendered*. All these shares have been accepted for payment and all holders of these shares will promptly be paid.

The subsequent offering period may be extended as described in the offer to purchase mailed to Genoptix's shareholders and filed with the U.S. Securities and Exchange Commission.

Contact
Novartis Central media line : +41 61 324 2200 Eric Althoff Novartis Global Media Relations T.: +41 61 324 7999 M.: +41 79 593 4202 E.: eric.althoff@novartis.com

--- END press release Novartis to commence subsequent offering period for Genoptix, Inc. ---

  Novartis (company entry)